Disrupt CAD III Post-Approval Study (PAS)

Study Overview
=================
Brief Summary
-----------------
The study design is a prospective, multicenter, observational, single-arm post-approval study using data collected in the National Cardiovascular Data Registry (NCDR®) CathPCI Registry®.

Detailed Description
-----------------
Subject Population: Patients ≥18 years of age with severely calcified, stenotic de novo coronary artery lesions presenting with stable, unstable, or silent ischemia that are suitable for percutaneous coronary intervention (PCI) and with clinical characteristics similar to the Disrupt CAD III IDE study. Approximately 1000 patients in the CathPCI Registry® (including a minimum of 30 patients with permanent pacemakers [PPM] or implantable cardioverter defibrillators [ICDs]) will be enrolled. Subjects will be followed through discharge. A minimum of 150 patients will be followed 30 days post-procedure.

Official Title
-----------------
New Enrollment Post Approval Registry for the Shockwave Intravascular Lithotripsy (IVL) System With Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter

Conditions
-----------------
Coronary Artery Disease, Myocardial Infarction

Intervention / Treatment
-----------------
* Device: Shockwave C2 Coronary IVL


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Subject is ≥18 years of age Subjects with native coronary artery disease (including stable or unstable angina and silent ischemia) suitable for PCI Left ventricular ejection fraction >25% within 6 months The target lesion must be a de novo coronary lesion that has not been previously treated with any interventional procedure LAD, RCA or LCX (or of their branches) with: Stenosis of ≥70% and <100% or Stenosis ≥50% and <99% (visually assessed) with evidence of ischemia via positive stress test, or fractional flow reserve (FFR) value ≤0.80, or iFR <0.90 or IVUS or OCT minimum lumen area ≤4.0 mm² The lesion length must not exceed 40 mm The target vessel must have TIMI flow 3 at baseline (visually assessed; may be assessed after pre-dilatation) Evidence of calcification at the lesion site by angiography, with fluoroscopic radio-opacities noted without cardiac motion prior to contrast injection involving both sides of the arterial wall in at least one location Exclusion Criteria: Subject experienced an acute MI (STEMI or non-STEMI) within 30 days prior to index procedure New York Heart Association (NYHA) class III or IV heart failure Renal failure with serum creatinine >2.5 mg/dL or chronic dialysis Subjects in cardiogenic shock or with clinical evidence of acute heart failure Target lesion is located in a native vessel that can only be reached by going through a saphenous vein or arterial bypass graft Previous stent within target lesion (in-stent restenosis)

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Disrupt CAD III PAS Cohort<br>Patients in the CathPCI Registry who undergo a PCI procedure using a Shockwave C2 Coronary IVL catheter and meeting the eligibility criteria will be included in the PAS cohort. A minimum of 150 patients with 30-day follow-up will be included in the PAS cohort. | Device: Shockwave C2 Coronary IVL<br>* PCI procedure using a Shockwave C2 coronary IVL catheter<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| All-cause death |  | Up to hospital discharge, approximately 24-48 hours | 
| Procedure-related adverse events |  | Up to hospital discharge, approximately 24-48 hours | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Intravascular Lithotripsy, Percutaneous Coronary Intervention